Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Topical finasteride may help improve hidradenitis suppurativa symptoms.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

A new finasteride treatment may quickly and effectively promote hair regrowth.

The spray makes hair styling easier and less greasy, improving minoxidil use.

Amalaki improves health in many areas, including cholesterol, blood sugar, and liver function, with no serious side effects.

The new delivery method for dutasteride is more effective and has fewer side effects.

Low-dose oral minoxidil alone is effective for treating hair loss, but combining it with dutasteride or finasteride may offer better results.

A hair tonic with 7.5% daun talok and 2% daun pare promotes hair growth as effectively as minoxidil.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

LAAM caused developmental toxicity in tolerant rats without causing birth defects.

Using Decamethoxine and Blastomunil together speeds up wound healing.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Microemulsions improve adapalene's skin absorption for better acne treatment.

Amalaki improves cholesterol, blood sugar, inflammation, and liver function without serious side effects.

Dupilumab for atopic dermatitis can cause mild skin issues in some patients.

Minoxidil works better for female hair loss than alfatradiol, both safe.

Mogamulizumab can cause hair loss and skin rashes.

Dupilumab can cause rare side effects like a rash on the face and neck.

A new method accurately measures DHEAS in blood, improving on current tests.

DDAIP-HCl significantly increases minoxidil absorption into the skin.

ALA-photodynamic therapy helps reduce acne by causing acne cell death and lowering certain skin protein levels.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

The solid microneedle booster improves hair regrowth and follicle enrichment when used with minoxidil.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

DDS treatment for LABD can cause severe side effects like anemia and hair loss, requiring careful monitoring.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.